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Background: The bacterial second messenger c-
di-GMP is degraded by EAL phosphodiesterases.
Results: The isolated EAL domain is active only 
as a homodimer. Substrate binding is coupled 
with EAL dimerization.
Conclusion: Activity of many full-length EAL 
phosphodiesterases may be regulated by catalytic 
domain dimerization.
Significance: A generic mechanism for the 
regulation of a central node of c-di-GMP 
signaling is provided.
ABSTRACT
The universal second messenger cyclic di-
GMP (cdG) is involved in the  regulation of a 
diverse  range of cellular processes in bacteria. 
The intracellular concentration of the 
dinucleotide  is  determined by the opposing 
actions of diguanylate  cyclases  (DGCs) and 
cdG specific phosphodiesterases (PDEs). While 
most PDEs have accessory domains that are 
involved in  the  regulation of their activity, the 
regulatory mechanism of this class  of enzymes 
has remained unclear. Here, we use biophysical 
and functional analyses to show that the 
isolated EAL domain of a PDE from E. coli 
(YahA) is in  a fast thermodynamic monomer - 
dimer equilibrium, and that the  domain is 
active  only in  its dimeric state. Furthermore, 
our data indicate  thermodynamic coupling 
between  substrate  binding and EAL 
dimerization with the  dimerization affinity 
being increased about 100-fold upon substrate 
binding. Crystal  structures of the YahA-EAL 
domain determined under various conditions 
(apo, Mg2+, c-di-GMP/Ca2+ complex) confirm 
structural coupling between the dimer 
interface  and the catalytic center. The in-built 
regulatory properties of the  EAL domain 
probably facilitate its modular, functional 
combination  with the  diverse  repertoire  of 
accessory domains.
Most  bacteria can exist  in two fundamentally 
different  life styles, as motile single cells and as 
sessile, surface-grown communities called 
biofilms. The switch between these two cellular 
states is mediated by the global second messenger 
cyclic-di-GMP (cdG)(1). While low levels of cdG 
promote planktonic behavior, increasing cdG 
concentrations curb motility, block the expression 
of toxins and virulence factors, and promote the 
expression of adhesion factors and a range of 
different  sugar polymers forming the biofilm 
matrix (2).
CdG synthesis is catalyzed by the GGDEF 
domains of diguanylate cyclases (DGCs), whereas 
its degradation is mediated by phosphodiesterases 
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(PDEs) that  contain EAL or HD-GYP domains. 
These abundant  and widespread catalytic domains 
are typically part  of multi-domain proteins that 
also carry regulatory domains involved in signal 
input  (PAS, BLUF, Rec etc.). In this way, various 
environmental or endogenous input  cues can 
control cellular cdG levels. The regulation of 
DGCs has been studied in detail for PleD from C. 
crescentus (3, 4) and for WspR from P. 
aeruginosa (5). Based on these experiments, an 
"activation by dimerization" mechanism was 
proposed (reviewed in (6)). More recently, a study 
on the DGC DgcZ from E. coli has expanded this 
view by proposing an additional mechanism in 
which zinc ion mediated rigidification of the input 
domain allosterically impedes enzyme activity 
(7).
EAL-type PDEs hydrolyze cdG in the 
presence of Mg2+ or Mn2+ to yield the linear 
pGpG dinucleotide (8, 9). A catalytic mechanism 
for this class of enzymes was first proposed by 
Liang and coworkers (10) based on mutagenesis 
in RocR and the crystal structure of the isolated 
EAL domain (TdEAL) of a PDE from T. 
denitrificans (PDB code 2r6o). The crystal 
structure of the YkuI/cdG/Ca2+ complex later 
revealed the spacious substrate-binding site at the 
C-terminal end of the central β-barrel (11). 
Finally, based on the substrate/Mn2+ complex 
s t r u c t u r e o f t h e a c t i v e B L U F - E A L 
phosphodiesterase BlrP1 from K. pneumoniae, a 
two-metal assisted catalytic mechanism was 
proposed with each of the two manganese ions 
coordinating the hydrolytic water molecule 
positioned in-line with the scissile phosphodiester 
bond (12). This was later confirmed by the 
TdEAL complex structure in presence of 
magnesium (13). The substrate complex structure 
of BlrP1 in presence of calcium revealed a 
somewhat  distinct coordination geometry with 
only one of the ions coordinated by the hydrolytic 
water (12) and, thus, rationalized the observation 
that calcium is inhibiting the enzyme (8). 
However, not all EAL domains are 
catalytically active. Some, such as YkuI, show 
degenerated active sites, but are still able to bind 
cdG. Apparently, they have adopted a role as 
highly specific cdG receptors that are thought  to 
generate an output via their associated domain(s) 
upon second messenger binding to the EAL 
domain (14, 15).
YahA from E. coli is a PDE (9) with an N-
terminal LuxR-like DNA binding domain. In vivo, 
i t  h a s b e e n d e m o n s t r a t e d t h a t  Ya h A 
overexpression confers a PDE phenotype (16). As 
a first  step towards the understanding of the 
regulatory node represented by YahA, we 
embarked on a detailed and quantitative structure-
function study of its catalytic EAL domain. The 
study revealed that  the YahA-EAL domain has 
intrinsic regulatory properties that are likely of 
general relevance.  Although the substrate-binding 
site is completely contained within the monomer, 
(i) PDE activity is dependent on the quarternary 
state of the EAL domain and (ii) cdG binding 
stabilizes the dimeric state. We propose that these 
are general properties of multi-domain EAL 
proteins.
EXPERIMENTAL PROCEDURES
Cloning, Expression and Purification- Two 
constructs of the EAL domain of YahA from E. 
coli were generated by cloning the coding 
sequence for residues 96-362 and 101-362  into 
pET21b and pET28a vectors (Novagen), 
respectively,  between the NdeI and NotI 
restriction sites.  This yielded constructs YahA96 
and YahA101 with a C- and N-terminal 6-His tag, 
respectively. In addition, two single residue 
mutants (D263N and S298W) were also 
constructed in the YahA96 and YahA101 
background, respectively. All protein variants 
were overexpressed and purified using the 
following protocol.
Protein was expressed in BL21 (DE3) host 
cells in LB media in presence of 50 µg/ml 
Ampicillin or Kanamycin. At OD600 ~ 0.6, the 
incubation temperature was shifted to 30 ºC and 
the growing culture was induced with 0.2 mM 
IPTG. Cells were finally harvested 4 hours post 
induction by spinning the cultures at 10,000 rpm 
(Sorvall SLA3000 rotor) for 10 minutes. The cell 
pellet was resuspended in buffer A (50 mM Tris-
HCl pH 8.0, 250 mM NaCl, 20 mM imidazole) 
with protease inhibitor cocktail supplied by 
Roche. Cells were lysed using a French press in 
two cycles and the lysate was centrifuged for 30 
minutes at 20,000 rpm (Sorvall SS34 rotor) and 4 
ºC to remove any suspended particles. Clear 
supernatant  was collected and loaded on a Ni-
NTA affinity column. The column was washed 
with plenty of buffer A until the baseline was 
reached and the bound protein was eluted with a 0 
to 50% linear gradient  of buffer B (50 mM Tris 
HCl pH 8.0, 250 mM NaCl, 1.0 M imidazole) in 
buffer A.
Fractions containing the desired protein were 
pooled and concentrated to a final volume of 4 - 5 
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ml. The concentrated protein was filtered using 
0.22 µm membrane and then loaded on a 
Superdex S200-26/60 gel filtration column in 
SEC buffer (50 mM Tris-HCl pH 8.0, 250 mM 
NaCl). Eluted protein peak was collected and 
pooled. The protein was quantified by recording 
absorbance at 280 nm and stored at -20 ºC at ~ 0.5 
mg/ml concentration.
Preparation of cdG- CdG was produced 
enzymatically using a previously reported method 
(17) by employing a product-inhibition-deficient 
mutant of diguanylate cyclase DgcZ (a.k.a. 
YdeH). The dinucleotide was purified from 
residual GTP, GDP and phosphate in a reversed-
phase co lumn chromatography wi th a 
Resource-15 RPC column (3 ml, GE Healthcare) 
with triethyl-ammonium-bicarbonate as the 
starting buffer and ethanol as the eluent. After 
removing the volatile buffer and the eluent  by 
freeze-drying, the powder was dissolved in water. 
Concentration of the nucleotide was calculated by 
recording absorbance at  253 nm and using an 
absorption coefficient of 28'590 M–1cm–1 (18). 
The purity of the product  was checked by mass 
spectrometry.
Crystallization and data collection- High 
resolution crystal structures were determined of 
WT YahA-EAL in its apo state, as well as of the 
binary Mg2+ complex and the ternary cdG/Ca2+ 
complex . Tab le 1 p rov ides de ta i l s o f 
crystallization conditions and ligands/cofactors 
present  in the crystallization drops. In its apo 
form, the protein was crystallized at  8 mg/ml. To 
grow complex crystals, the protein was 
concentrated in the presence of 2 mM CaCl2 (or 
MgCl2). cdG was then added to the concentrated 
protein to yield a final concentration of 8 - 10 mg/
ml protein with a 1:5 molar ratio of protein to 
cdG. 
Crystallization of all the proteins was carried 
out using sitting drop vapor diffusion method at 
20 ºC by mixing the protein with the reservoir 
solution in 1:1 ratio. All single crystal X-ray 
diffraction datasets were collected at  PXIII beam 
line of Swiss Light source, Villigen, Switzerland. 
For the YahA-EAL-apo crystal, a total of 150 
diffraction images (Δφ = 10, t  = 1 s) were 
collected. 800 diffraction images (Δφ = 0.25, t = 
0.25 s) were collected for each of the complex 
crystals.
Structure solut ion and ref inement- 
Diffraction datasets were processed either with 
MOSFLM (19) or XDS (20) and the resulting 
intensities were scaled using SCALA (21) from 
CCP4i suite. At this step, a set of 5% reflections 
(Rfree set) was taken out for cross-validation (22). 
All the three structures were solved by 
molecular replacement  using program Phaser 
(23). For the determination of the YahA-EAL apo 
structure, a YahA-EAL homology model based on 
TdEAL (PDB ID – 2R6O) was used. For solving 
the complex structures, the refined apo YahA-
EAL structure was used as search model. 
Further refinement  of structures was carried 
out using REFMAC5 (24). Model building was 
performed using COOT  (25). Side chains for 
some residues were omitted based on the 2Fo-Fc 
map. Ligand molecules and metal ions were 
modeled in the Fo-Fc difference electron density 
map. Finally, water molecules were placed where 
the Fo-Fc map exceeded 3σ and potential 
hydrogen bonds could be formed. Model 
validation was carried out with PROCHECK (26). 
All structure figures were produced by using 
DINO (http://www.dino3d.org).
Microscale thermophoresis (MST) binding 
assay- CdG affinity to the EAL domain was 
measured by microscale thermophoresis (27) in 
competition experiments with fluorescein labeled 
cdG (2'-Fluo-AHC-c-diGMP, Biolog, Bremen, 
Germany; fl-cdG). The experiments were 
conducted in a Monolith NT.115T  device using 
standard treated capillaries (NanoTemper 
Technologies). Changes in fluorescence intensity 
due to thermophoresis were recorded using the 
blue channel optics of the instrument  (λex = 
470±15 nm, λem = 520±10 nm), during a 30 s 
period of infrared laser heating at 70 % of 
maximum laser power followed by a 5 s cooling 
period. Measurements were performed in a buffer 
containing 50 mM Tris-HCl, pH 8.0, 250 mM 
NaCl and 0.1 % Tween 20. 2 mM CaCl2 or MgCl2 
was added to the buffer when required.
For each protein and each set  of conditions, 
a binding titration and a competition titration were 
conducted. For the binding titration, a varying 
concentration of protein (a 16 point 1:1 serial 
dilution series) was titrated against  a fixed 
concentration of fl-cdG (60 nM). In this 
experiment, the relative change in fluorescence 
intensity due to thermophoresis at different 
concentrations of protein reported on the binding 
of fl-cdG to the protein. For the competition 
titration, a varying concentration of unlabeled 
cdG was titrated against  the same fixed 
concentration of fl-cdG (60 nM) and protein (at  a 
concentration determined from the first titration, 
see Tab. 3). In this experiment, the relative change 
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in fluorescence intensity due to thermophoresis at 
different  concentrations of protein reported on the 
displacement of fl-cdG from the protein by 
unlabeled cdG.
For evaluation, data were fitted (program 
ProFit, Quansoft, Zurich, Switzerland) to a ligand 
competition model with ligands L1 and L2 
competing for the same binding site on a protein 
P. The concentration of the three protein states (P, 
PL1, PL2) were calculated from the total 
concentrations ([P0], [L10], [L20]) according to 
the analytical solution of the problem (28). As 
parameters, the model contains the dissociation 
constants of labeled and unlabeled ligand, Kd1 = 
[L1]⋅[P]/[PL1] and Kd2 = [L2]⋅[P]/[PL2], 
respectively, and two scale factors that relate the 
fluorescence signal I of free and bound fl-cdG to 
their concentrations (Ifree = sc1⋅[L1], Icompl = 
sc2⋅[PL1]). Additionally, the factor sc3 was 
introduced to correct  for errors in protein 
concentration due to protein loss in the capillary 
and uncertainty in the protein extinction 
coefficient that  was used for concentration 
determination.  This factor was only refined, 
when the competition data revealed clearly that 
the fl-cdG was already fully competed out at a 
[cdG] < [protein] and adopted values in the range 
between 0.45 and 0.78. Confidence intervals were 
estimated by a Monte-Carlo method implemented 
in ProFit, assuming a fixed 5 % error on each data 
point.
Size exclusion chromatography (SEC) 
coupled with multi-angle light scattering (MALS) 
- A Wyatt  silica SEC column (4.6x300 mm, 5 µm 
bead, 300 Å pore) on an Agilent  1100 series 
HPLC was employed for the determination of the 
oligomeric state of YahA-EAL under different 
conditions. The instrument  was coupled with a 
Wyatt miniDawn TriStar multi-angle light 
scattering detector and a Wyatt  Optilab rRex 
refractive index detector. The column was 
equilibrated for three hours to obtain stable 
baseline signals from the detectors before data 
collection. The inter-detector delay volumes and 
band broadening, the light-scattering detector 
normalization, and the instrumental calibration 
coefficient  were calibrated using a standard 2 mg/
ml BSA solution (Thermo Pierce) run in the same 
buffer, on the same day, according to standard 
Wyatt protocols. The absolute refractive index of 
the buffer was measured using the refractive 
index detector.
The protein sample (20 µL) was loaded on 
the column in absence or presence of substrate 
cdG (5:1 molar ligand/protein ratio) and/or 
divalent cations (2 mM CaCl2 or MgCl2). All 
experiments were performed at 6 ºC at a flow rate 
of 0.4 ml/min in SEC buffer (see purification 
section). Where appropriate, the SEC buffer 
contained in addition 2 mM CaCl2 or MgCl2, but 
no cdG was added to any running buffer.
The molecular weight  and mass distribution 
of the sample were then determined using the 
ASTRA 5 software (Wyatt  Technology). The 
occupancy of the EAL/cdG complexes at  elution 
was calculated from the UV peak areas of the apo 
and the complexed protein. No loss of sample on 
the column and an unchanged extinction 
coefficient  of cdG upon binding were assumed. 
The extinction coefficient  of  cdG (εcdG(280) = 
17160 M-1cm-1) was calculated from the 
published εcdG(253)=28.6⋅103 M-1cm-1 (18) and 
the measured cdG absorption spectrum. For the 
protein, an εYahA-EAL(280) of 27180 M-1 cm-1 was 
o b t a i n e d f r o m t h e E x p a s y s e r v e r 
(www.expasy.org).
SEC-MALS derived apparent mass values 
(Fig. 6C) were used to derive the dimerization 
affinity of YahA-EAL under various conditions, 
assuming a fast  monomer -  dimer equilibrium. 
According to the mass action law, the monomeric 
molar fraction, xm = [M]/[M0], is given, by
xm = [ (8⋅[M0]⋅Kd + Kd2)1/2 - Kd ] / (4⋅ [M0] )    
(1)
with [M0] = [M] + 2⋅[MM], total protein 
concentration at elution; [M], monomer 
concentration; [MM], dimer concentration.
This yields for the weight-averaged apparent 
mass (see also (29))
mapparent = xm⋅mmono + (1-xm)⋅mdimer = (2-xm)⋅mmono  
(2)
The experimental data (Fig. 6C) were fitted 
(program ProFit) to equation 2 with a fixed mmono 
of 31 kDa to yield the dimerization Kd.
A n a l y t i c a l u l t r a c e n t r i f u g a t i o n - 
Sedimentation equilibrium runs were conducted at 
8 ºC using An-50Ti rotor in a Beckman Coulter 
XL-I analytical ultracentrifuge. The YahA-EAL 
protein in SEC buffer supplemented with 2 mM 
CaCl2 was subjected to ultracentrifugation in the 
presence of cdG ( 1.25 : 1 molar cdG/protein 
ratio). For each protein concentration (1 µM, 2 
µM), three runs (9700, 16500, and 28000 rpm) 
were performed. The radial absorption profiles 
(range r = 7.01 to 7.17 cm) were fitted globally 
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(Fig. 7) to a monomer - dimer self-association 
model (equation 10 in (30)) to yield the 
dimerization Kd. The contribution of free cdG 
ligand was neglected and subsumed in the base 
line.
Enzymatic assay- Enzymatic activity was 
assayed off-line by FPLC based steady-state 
nucleotide quantification following incubation for 
varying durations. Enzymatic reactions were 
carried out at room temperature in 50 mM Tris-
HCl, pH 9.35, 50 mM NaCl, 5 mM MgCl2, 0.5 
mM EDTA and 50 µM thiamine pyrophosphate 
(TPP) as FPLC standard. In all experiments, 
saturating substrate concentration (20 µM) was 
used. The reaction was started by addition of 
enzyme (100x concentration) to a total reaction 
volume of 600 µL. Samples of 100 µL volume 
were withdrawn and the reaction stopped at 
different  time points by addition of 10 µL of 100 
mM CaCl2.
The samples were then analyzed using ion-
exchange chromatography (1 mL Resource-Q 
column) after addition of 890 µL of 5 mM 
ammonium bicarbonate (NH4CO3) to increase the 
volume to 1 mL. 500 µL of this was then loaded 
onto the column. The column was washed 
thoroughly and the bound nucleotides were eluted 
with a linear NH4CO3 gradient (5 mM to 1 M) 
over 17 column volumes. The identity of the 
e lu t ing spec ies was ver i f i ed by mass 
spectroscopy.
The amount  of pGpG product was 
determined by integration of the corresponding 
absorption (253 nm) peak after normalization of 
the data with respect to the internal TPP standard. 
Fo r each ( [M0] , [S ] ) combina t ion o f 
concentrations, the progress curve was fitted to a 
simple Michaelis-Menten kinetics model (Fig. 
8B) yielding the specific activity kcat,meas. 
Assuming a fast  monomer-dimer equilibrium, the 
apparent specific activity is given by 
kcat,meas = kcat,mono ⋅ xm + kcat,dimer⋅(1-xm)      (3)
with kcat,mono, kcat,dimer: specific activity (turnover 
number) of monomer and dimer, respectively, and 
xm given by eq. (1).
Thermodynamic model of ligand induced 
dimerization- For the derivation of the 
thermodynamic coupling between ligand binding 
and dimerization consider the scheme shown in 
Fig. 9. Monomer (M) and dimer (MM) are in 
thermodynamic equilibrium. A ligand L binds to 
the monomer to form a monomeric ligand 
complex (LM). This can associate to form a 
dimeric ligand complex (LMML). In addition, a 
singly occupied dimer (LMM) has to be 
considered. The indicated second-order 
association constants refer to dimerization (K00, 
K11) or ligand binding (Ks1, Ks10, Ks11) with
K00 = [M] ⋅ [M] /[MM]     (4a)
K11 = [LM] ⋅ [LM] /[LMML]     (4b)
Ks1 = [L] ⋅ [M] /[LM]     (4c)
Ks10 = [L] ⋅ [MM] /[LMM]     (4d)
Ks11 = [L] ⋅ [LMM] /[LMML]     (4e)
 In addition, a third-order association 
constant  K'11 is defined which also related species 
LM and LMML
K'11 = [LM] ⋅ [M] ⋅ [L]/[LMML]        (5).
with 
[L] ⋅ [M] = Ks1 ⋅ [LM]   (4c')
we get
K'11 = Ks1 ⋅ [LM]⋅[LM] /[LMML] = Ks1 ⋅ K11  (5').
Since the scheme shown in Fig. 9 represents 
a thermodynamic cycle, the state LMML can be 
reached via two routes both starting from state M. 
Therefore, not  all association constants are 
independent, but they are coupled by
K00 ⋅ Ks10 ⋅ Ks11 = Ks1 ⋅ K'11 = Ks1 ⋅ Ks1 ⋅ K11    (6)
Assuming no cooperativity in ligand binding to 
the dimer (Ks10 = Ks11)
K00 ⋅ Ks102  = Ks12 ⋅ K11   (6')
yielding finally
K11 /K00 = (Ks10/Ks1)2   (7)
Finally, introducing dissociation constants 
Kd,11=1/K11, Kd,00=1/K00, Kd,s10=1/Ks10, 
Kd,s1=1/Ks1, we get the equivalent relation 
Kd,11 /Kd,00 = (Kd,s10/Kd,s1)2   (7').
Thus, any difference in the dimerization 
propensity of the liganded vs. unliganded state is 
coupled to a difference in ligand affinity to the 
dimeric vs. monomeric state.
RESULTS
Structural basis- The EAL domain of YahA 
(YahA-EAL) was cloned and expressed as His-
tagged fusion protein. It was purified to 
homogeneity and crystallized in various 
conditions by vapor diffusion. High resolution 
crystal structures were determined of the apo 
protein (space-group I222, 1 mol/a.u., 1.7 Å), the 
Mg2+ complex (P21, 4 mol/a.u., 2.4 Å) and the 
ternary cdG/Ca2+ complex (P21, 2 mol/a.u., 1.7 
Å). Data processing, structure refinement and 
validation statistics are shown in Table 1. The 
modified triosephosphate isomerase (TIM)-barrel 
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fold (αβ(βα)7) of YahA-EAL (Fig. 1A) shows 
close similarity to other EAL structures such as 
YkuI (11), BlrP1 (12) or TdEAL (13). The 
primary structure of YahA-EAL with assigned 
secondary structure elements and conservation 
logo is shown in Fig. 2. All residues that  are 
important for catalysis (13, 31) are conserved.
In the presence of Mg2+, YahA-EAL forms a 
2-fold symmetric dimer (Figs. 1D,F and 3A,C) 
with the β5-α5 loop, and the α5 and α6’ helices 
forming i so logous contac ts wi th the i r 
counterparts. The residues involved in the 
interaction are well conserved with a buried 
surface area of 1100 Å2. While such dimers have 
been observed in almost all known EAL crystal 
structures (for a survey, see (32)), the details of 
the interactions and the relative orientation of the 
two domains vary somewhat. Since, in solution, 
YahA-EAL/Mg2+ is monomeric up to a 
concentration of 10 µM (see below), dimers were 
probably stabilized by the high protein 
concentration (260 µM) used for crystallization or 
have been incorporated selectively into this 
crystal form.
Figure 4A shows that  at  the C-terminal end 
of the central β-barrel a magnesium cation (M1) is 
coordinated by E141 (of the EAL motif), N200, 
D262, and E232, analogous to the situation in the 
binary TdEAL/Mg2+ complex (13) (Tab. 2). Since 
the metal site is fully occupied and the structure 
was obtained at physiological magnesium 
concentration (2 mM) (33), it  is likely that in vivo 
YahA-EAL is constitutively complexed with 
magnesium.  Adjacent to the M1 site, there is an 
unusual cluster of acidic side-chains, with D263 
(the second aspartate of the conserved DD motif 
(Fig. 2) at the end of β5) in H-bonding distance to 
the conserved residues E235 and E319. Thus, 
some of the residues should be protonated, 
irrespective of the close to neutral crystallization 
and protein buffer conditions (pH 6.5 and 8.0, 
respectively). In addition, the conserved residue 
D285 is at close distance (3.2 Å). 
When the protein was crystallized in absence 
of divalent cations, a different crystal form was 
obtained (Tab. 1) in which YahA-EAL forms a 
disulfide-linked dimer employing C131 and its 
symmetry mate C131*. This is  probably a 
crystallization artifact, considering the reducing 
environment  under physiological conditions, the 
residue variability at  this position (Fig. 2), and the 
fact that in solution only EAL monomers were 
observed even in absence of reducing agent (see 
further below). The overall fold is virtually 
identical to that  of the YahA-EAL/Mg2+ complex 
with the notable exception of changes in the β5-
α5 loop (Fig. 1C), which makes few 2-fold 
symmetric contacts with the β5-α5 loop of a 
symmetry-related molecule . The conformation of 
the loop, which shows high B-factors, is 
incompatible with the tight  canonical YahA-EAL/
Mg2+ dimer (Fig 1D). This re-enforces the notion 
that EAL dimerization is coupled with β5-α5 loop 
conformation (31).  
Substrate complex structure- The structure 
of the enzyme in complex with substrate was 
determined in the presence of 2 mM calcium to 
prevent substrate turnover (9).  The structure is 
virtually identical to the apo and magnesium 
complex structures (Figs. 1A-C). Unexpectedly, 
the ternary YahA-EAL/cdG/Ca2+ complex showed 
a non-canonical dimeric assembly (Figs. 1E,G 
and 3B,D), which was also observed in two other, 
low resolution crystal forms grown under 
different  crystallization conditions. The dimer 
interface (1400 Å2) overlaps largely with the 
canonical β5-α5 loop, α5, α6' interface, but  in 
addition, involves the α6 - α6' loop (290 loop). 
Since this loop is not  conserved amongst EAL 
homologs (Fig. 2), the physiological relevance of 
this interaction and thus of this dimeric 
arrangement is unclear, but might fulfill a YahA 
specific task. 
Note that the dimerization loop (β5-α5 loop) 
adopts distinct  conformations dependent  on the 
ligation state (magenta loop in Figs. 4A,B and 5). 
The relevance of this loop (“loop 6”) for catalysis 
has been recognized before by mutagenesis in 
RocR (10) and evidence for its flexibility has 
been obtained by deuterium - hydrogen exchange 
experiments (31). The conformation of the β5-α5 
loop is correlated with distinct side-chain 
orientations of E235 from the adjacent  β4-α4 loop 
(Fig. 5). This highly conserved “anchoring 
glutamate” interacts with the β5-α5 loop and its 
mutation to alanine in RocR (E268A) rendered 
the enzyme inactive (10).
 As observed for other EAL domains (see 
(32) and references therein), the substrate is 
bound to an extended shallow groove at the C-
terminal end of the β-barrel (Fig. 4B). There are 
two calcium ions, one bound to the M1 site (with 
identical coordination as in the Mg2+ complex), 
and the other (M2) coordinated by D263, E285, 
and E319, i.e. residues that  form the acidic cluster 
in the Mg2+ complex (Fig. 4A). Each of the non-
bridging oxygens of the proximal phosphate is 
within coordinating distance to one of the Ca2+ 
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ions. A water molecule (W) is positioned in-line 
with the scissile O3' - P  bond, but is coordinated 
only with M1 (Fig. 4B).
A very similar arrangement  has been 
described for the ternary cdG/Ca2+ complex of 
BlrP1 (12), where substitution of Ca2+ against the 
active cofactor Mn2+ resulted in a significant shift 
of M2 and brought  this cation within coordinating 
distance of the catalytic water (Fig. 4C). 
Correspondingly, Barends et  al. proposed a two-
metal assisted catalytic mechanism with both 
cations activating the water and defining the 
precise relative orientation of the water (W) and 
the proximal phosphate moiety. The same 
constellation was observed later for TdEAL/cdG/
Mg2+ (13) and can thus be predicted to represent 
the competent metal constellation for YahA-EAL 
as well. 
In the cdG/Ca2+ and in the Mg2+ complex, an 
unknown small molecule, tentatively assigned as 
trans-4-(hydroxymethyl) cyclohexanol was found 
on the barrel axis at the center of the domain. In 
the apo structure, a PEG400 molecule was 
identified at  the same position. Though the 
presence of these molecules is probably 
artifactual, they identify a large hydrophobic 
cavity close to the active site that may be 
occupied in vivo by a bioactive factor.
Substrate affinity- The affinity of YahA-
EAL for cdG was measured by Microscale 
Thermophoresis (MST) in a competition assay 
using fluorescein-labeled cdG as a reporter (fl-
cdG; Fig. 6A, Tab. 3). Due to substrate turnover it 
was not  possible to determine fl-cdG and cdG 
affinity in presence of magnesium. With calcium 
as cofactor, YahA-EAL binds the substrate 
extremely tightly (Kd ≤ 1 nM), while in absence 
of divalent  cations, the substrate affinity is still 
considerable (Kd about 20 nM, Tab. 3). This can 
be understood by the multitude of interactions the 
substrate undergoes with the binding site (Fig. 
S5).  CdG affinity has been measured before only 
for the degenerated EAL domain of the FimX 
receptor (14). Although the protein lacks the 
conserved cation binding sites, it again showed 
tight cdG binding (Kd about 100 nM), similar to 
that of YahA-EAL in absence of cations. 
Fast cdG dependent EAL monomer - dimer 
equilibrium- The oligomeric state of YahA-EAL 
was probed by size exclusion chromatography 
(SEC) coupled with multi-angle light-scattering 
(MALS) (Figs. 6B,C) and sedimentation-
equilibrium analytical-ultracentrifugation (AUC-
SE, Fig. 7). The SEC-MALS data indicated that 
retention time and apparent  mass values are 
dependent on the YahA-EAL concentration (Fig. 
6C), which is indicative of a self-association 
equilibrium that  is fast on the time scale of the 
experiment. The weight-averaged mass values 
were fitted to the appropriate monomer-dimer 
equilibrium model (see Methods) and the results 
are summarized in Tab. 4. The protein is largely 
monomeric up to the maximal loading 
concentration (180 µM), both in absence or 
presence of magnesium. Magnesium and calcium 
shift  the equilibrium somewhat (by a factor of 5 
and 14, respectively) towards the dimeric state. 
However, upon addition of cdG to YahA-EAL/
Mg2+ (the probable constitutive form of the 
protein present in vivo) the dissociation constant 
is appreciably reduced (40-fold) to a value of 0.6 
µM as derived from the MALS data. The potential 
relevance of this cdG induced dimerization effect 
for the mechanism of degenerate EAL effectors 
(receptors) is discussed further below.
For the substrate complexes, the fit of the 
MALS data yields only apparent  dimer 
dissociation constants, since cdG was not  present 
in the running buffer. In fact, at  elution, the 
protein showed a sub-stoichiometric amount of 
bound nucleotide (about  70% as calculated from 
peak absorption and refractive index values, see 
Methods). A similar Kd,apparent was obtained with 
magnesium as divalent  cation, suggesting that 
conversion of the cdG substrate to the pGpG 
product  does not affect the oligomeric state of the 
enzyme significantly. Finally, the proper 
equilibrium dimerization Kd of the ternary 
complex was determined by AUC-SE analysis 
(Fig. 7). Global fitting of the absorption profiles, 
acquired at three speeds and two protein 
concentrations to a self-associating monomer-
dimer system (30), yielded a dimerization Kd of 
0.4 µM (Tab. 4). Unfortunately, evaluation of the 
AUC-SE data for the apo-samples was not 
possible due to long-term aggregation of the 
samples.
For further functional studies, a mutant  was 
generated with the aim to prevent  dimer formation 
(both of the canonical and the closed dimer). A 
residue in the monomer-monomer interface, far 
away from the active site, was chosen (S298, see 
Fig. 1A) and replaced by the bulky tryptophan. As 
indicated by the SEC-MALS chromatogram (Fig. 
6B, bottom), the S298W protein is in slow 
monomer - dimer exchange with the equilibrium 
indeed largely on the monomeric side, in 
particular in presence of substrate. Similar 
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affinities, both of fl-cdG and c-di-GMP, were 
found with respect  to the dimer interface mutant 
S298W (Tab. 3), demonstrating an intact  binding 
site.
Catalytic activity is dependent on EAL 
concentration- It  had been suggested before by us 
(11) and others (12, 31, 34, 35) that  EAL 
phosphodiesterase activity may depend on the 
quarternary state or arrangement  of the catalytic 
domains, which in turn would be controlled by 
associated regulatory domains. We tested this 
hypothesis in a reductionistic approach by altering 
the monomer-dimer equilibrium of the isolated 
YahA-EAL domain through concentration 
variation or site-directed mutagenesis and 
concomitant measurement of the catalytic activity 
by FPLC-based nucleotide quantification (Figs. 
8A,B).
Figure 8C shows that  the specific catalytic 
activity of YahA-EAL indeed strongly depends on 
the enzyme concentration, converging to zero at 
low nM concentrations. The entire profile can be 
well fitted according to the law of mass action 
with monomers being inactive and dimers turning 
over the substrate with a kcat of 0.72 ± 0.06  s-1. 
This value is in the same range as those observed 
for PdeA (8), RocR (10), BlrP1 (12), and the 
isolated EcDos(EAL) domain (9, 32) at micro-
molar enzyme concentrations. Variation of 
substrate concentration did not affect  the rate of 
reaction (Fig. 8B) down to the lowest substrate 
concentration tested (5 µM), suggesting that the 
Km lies below this value. For unknown reasons, 
considerably higher specific activity and Km 
values (kcat = 17 s-1, Km = 35 µM) have been 
reported before for the isolated EAL domain of 
YahA (9). The YahA-EAL dimerization Kd, the 
remaining parameter of the kinetic model, is 0.5 
µM. This is in good agreement with the values 
measured by SEC-MALS and AUC-SE (Tab. 4). 
The mutant S298W shows drastically 
reduced activity (Fig. 8C) as anticipated from its 
predominantly monomeric state (Fig. 6B, 
bottom). The site of the mutation is both solvent-
exposed and distant  from the catalytic center, so 
any direct  effect of the mutation on that catalytic 
center appears unlikely. Since activity has been 
assayed at  high substrate concentration and, in 
presence of calcium, substrate binding is virtually 
unaffected by the mutation (Fig. 6A, Tab. 3), the 
reduced activity most  probably reflects a 
drastically reduced kcat.
DISCUSSION
This study focused on some remarkable 
functional and structural properties of a 
phosphodiesterase EAL domain in isolation. The 
structures reported here show YahA-EAL in 
various ligand-dependent conformational states 
and qualify it  as a prototypic catalytic EAL 
domain with dimerization propensity. Intriguingly, 
apart  from the canonical dimeric arrangement 
(11-13) found for YahA-EAL/Mg2+, the ternary 
substrate complex YahA-EAL/c-di-GMP/Ca2+ 
shows a different  subunit organization, though 
utilizing most of the canonical interface. Whether 
one or both dimeric configurations can be formed 
in full-length YahA must await  structure 
investigation. The "closed" dimer reported for 
FimX (14, 36), though similar in shape, uses a 
completely different interface.
The EAL domain is in a fast  ligand-
dependent monomer-dimer equilibrium. A 
corresponding thermodynamic model is shown in 
Fig. 9. Accordingly, the dimer association 
constants for the uncomplexed and complexed 
protein (K00 and K11, respectively) are not 
identical. This will be reflected in differential 
ligand binding to the two protein states according 
to  
K11/K00 = (Ks10/Ks1)2
with Ks1 and Ks10 being the ligand association 
constants to the monomeric and dimeric protein, 
respectively, and assuming no cooperativity (Ks10 
= Ks11), see Experimental Procedures. In terms of 
dissociation constants the relation will then read
Kd,11/Kd,00 = (Kd,s10/Kd,s1)2.
Obviously, this thermodynamic coupling 
between ligand binding and dimerization appears 
well suited to be utilized in second messenger 
signaling. CdG-induced EAL dimerization would 
constitute a massive output signal that could, for 
example, promote dimerization of other domains 
in the same protein. Similarly, cdG dependent 
EAL/EAL association in the context of a dimeric 
multi-domain receptors may trigger signaling as 
has been proposed for LapD based on crystal 
structures (15). For the FimX receptor, however, a 
different s ignal ing mechanism, namely 
competition between cdG and a protein domain 
for EAL binding, may be operational (14). 
What are the structural features that 
correspond to the observed thermodynamic 
coupling between cdG binding and dimerization? 
The YahA-EAL structures (Fig. 1) probed under 
various conditions show that  the β4-α4, β5-α5, 
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and 290 loops are exquisitely sensitive to the 
quarternary state and to the ligation state of the 
domain. These structural elements most probably 
represent the conduit  that transmits structural 
information between substrate binding pocket and 
dimer interface. Involvement of the β5-α5 loop 
and the interface in EAL regulation has been 
proposed before for YkuI, BlrP1 and RocR (11, 
12, 35). 
From the values in Table 4, the Kd,11/Kd,00 
ratio can be estimated to be about  0.4/36 = 1/90 in 
presence of magnesium, which yields a Kd,s10/Kd,s1 
ratio of 0.11, i.e. about  10-fold tighter binding of 
the substrate to the (catalytically competent) 
dimer than to the monomer.  Most probably, not 
this modest  difference in cdG affinity, but  the 
observed drastic change in kcat with only the 
dimer being catalytically active is crucial for the 
regulation of the enzyme in vivo. The inactive 
state of the monomer may be largely due to a 
compromised M2 site that prevents binding of the 
second Mg2+ ion, which has been shown to be 
catalytically indispensable in RocR (10) and in 
TdEAL (13). Indeed, we also found that  mutation 
of the M2 coordinating D263 to asparagine in 
YahA-EAL renders the enzyme inactive, but  does 
not compromise substrate affinity. Unfortunately, 
the crystal structure of an EAL/substrate/Mg2+ 
complex in the monomeric state (state 1 in Fig. 9) 
is not known and its determination may indeed be 
difficult, since, at the protein concentrations 
required for crystallization, cdG stabilizes the 
dimer. 
It  is probable that  the coupling of the 
specific activity kcat to the quarternary state/
structure ("activation by dimerization") is 
mediated by the same loop structures as discussed 
above. To allow binding of the magnesium ion 
M2 to the active site, we propose that  loop β5-α5 
and the "anchoring glutamate" E235 from loop 
β4-α4 (see Figs. 4 and 5) have to adopt 
conformations that allows D263 at the end of 
strand β5 to engage in M2 coordination. Finally, 
the proximal phosphate group of the substrate 
would complete the cation coordination shell, and 
catalysis would proceed.
In full-length YahA, the EAL domain is 
linked to a LuxR-like DNA binding domain. How 
the inherent properties of the isolated YahA-EAL 
are utilized in the full-length protein is subject to 
further research. In particular, it  will be interesting 
to see whether YahA is a DNA-dependent PDE or 
a cdG-dependen t t r ansc r ip t ion f ac to r. 
Nonetheless, the findings reported here may well 
be relevant for the understanding of a large 
variety of EAL domain proteins that  receive input 
from different accessory domains including PAS, 
BLUF, or REC (6). It  is particularly pertinent  that 
all known multi-domain EAL protein structures 
(YkuI, BlrP1, RocR, LapD, FimX) are dimeric or 
tetrameric and show canonical EAL/EAL 
interactions. However no structural information is 
available for any of these proteins both in the 
activated and inactivated state.
In the simplest case, the signal sensed by the 
input  domain will induce its homo-dimerization 
and synergistically drive the EAL/EAL 
equilibrium to the dimeric state, reminiscent  of 
Rec-HTH transcription factor activation by Rec 
domain dimerization (37).  For the Rec-EAL 
protein RocR, however, the situation seems to be 
more complex in that  a non-symmetric tetramer 
structure with partially occluded active sites has 
been observed (35). Alternatively, in the context 
of a constitutive dimer such as YkuI or BlrP1, the 
signal may induce a rearrangement  of input 
domains that, in turn, would affect  the EAL/EAL 
interface and hence PDE activity or cdG binding. 
For EcDOS, a scissor-like movement of the 
subunits in the isolated PAS dimer upon heme 
cofactor reduction has been reported (34). This 
motion may be propagated to the EAL domain 
that has been observed to exist as a canonical 
dimer in isolation (32). 
To conclude, a regulatory mechanism 
inherent in the catalytic domain of an enzyme as 
reported here for the EAL domain may have the 
evolutionary advantage that signal input and 
enzymatic response can easily be coupled in a 
modular way. Another activation by dimerization 
mechanism has been described, though very 
different  in detail, for the GGDEF domain of 
diguanylate cyclases (6, 7). Thus, such ease of 
combination, may explain the large repertoire of 
accessory domains known for EAL as well as for 
GGDEF domains.
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FIGURE LEGENDS
FIGURE 1. Crystal structures of the YahA-EAL domain. Cartoon representation with secondary structure 
elements and chain termini labeled. The β5-α5 loop is highlighted in magenta. (A) Structure of the 
monomer of YahA-EAL in complex with Mg2+  (M1). Mutation site S298 is shown in full and labeled. (B) 
Structure of the monomer of YahA-EAL in complex with substrate (cdG) and Ca2+ (M1 and M2). (C) 
Superimposition of YahA-EAL-apo (brown) with YahA-EAL/Mg2+ (steel-blue) and YahA-EAL/cdG/Ca2+ 
(light green). (D, F) and (E, G) Subunit arrangement in YahA-EAL/Mg2+ (canonical EAL dimer) and 
YahA-EAL/cdG/Ca2+ (closed EAL dimer), respectively. The asymmetric unit of YahA-EAL/Mg2+ 
contains two dimers, both are virtually identical. Same color as in panels A and B, but with symmetry 
mates shown in grey. In panels (D) and (E) the view along the symmetry axis. In panels (F) and (G), the 
view is approximately along the interface helices α6' and α6'* to demonstrate the relative screw rotation. 
Still, both dimers use the same interface formed by the β5-α5 loop and helices α5 and α6'. Note however 
that, in YahA-EAL/cdG/Ca2+ loop 290 is also part of the interface and that the inter-subunit distance 
between the N-termini (position P110) is reduced from 34 to 25 Å giving the dimer a closed appearance 
with the binding sites facing inside.
FIGURE 2. Sequence of the EAL domain of YahA from E. coli (UNIPROT accession name P21514) 
with experimentally determined secondary structure elements and HMM logo based on a non-redundant 
set of 62 EAL sequences. Important residues are labeled with their number. cdG binding residues are 
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shown in red. Metal coordinating residues are represented in boxes. The anchoring glutamate is shown in 
blue, whereas the general base lysine is in green. Other important residues are shown in black. 
FIGURE 3. YahA-EAL dimer interfaces.  (A), (C) Canonical YahA-EAL/Mg2+ dimer. (B), (D) "Closed" 
YahA-EAL/cdG/Ca2+ dimer. For each structure, two orthogonal views (front and top) are shown. 
Hydrogen bonds are represented as broken brown lines, divalent cations as spheres in magenta.
FIGURE 4. EAL active site structures in absence and presence of cdG substrate. Divalent cations are 
colored in green (Mg2+), yellow (Ca2+), or magenta (Mn2+). (A) YahA-EAL/Mg2+, (B) YahA-EAL/cdG/
Ca2+ (see also Fig. S5) and (C) BlrP1/cdG/Mn2+ (PBD ID 3GG0) (12). Water molecules are represented as 
red spheres, cation coordination bonds by black broken lines, and loop β5-α5 is highlighted in magenta. 
In (A), aspartate D263 is H-bonded (orange broken lines) to surrounding carboxylic side-chains. In (B) 
and (C), the hydrolytic water (W) is in-line with the scissile O3' - P bond of the cdG substrate (shown in 
full with cyan carbons). Note that the location of the "anchoring" glutamate (E235 in YahA, E275 in 
BlrP1) is distinct in the binary and ternary complexes.
FIGURE 5.  Loop β4-α4, β5-α5, and loop290 conformations of apo YahA-EAL (A), YahA-EAL/Mg2+ 
(B) and YahA-EAL/cdG/Ca2+ (C). The distinct interaction patterns between the "anchoring" glutamate 
(E235) and loop β5-α5 are represented by broken lines in brown.
FIGURE 6. EAL/substrate and EAL/EAL affinity. Concentration of divalent cations was 2 mM, where 
applicable. (A) Titration of cdG to YahA-EAL wild-type (squares) and S298W mutant (diamonds) 
resulting in displacement of fl-cdG (60 nM) from the protein as measured by MST. Data have been 
acquired in absence (black) or in presence of Ca2+ (red). The data were fitted to a ligand competition 
model (solid lines) (28) yielding the cdG dissociation constants given in Tab. 3. For the wild-type, fit 
curves for Kd = 0.1 (solid line) and 1.0 nM (broken line) are shown. (B) SEC-MALS chromatograms 
(loading concentration 180 µM) for Yaha-EAL wild-type (top) and the S298W mutant (bottom). The 
proteins were analyzed in absence of divalent cations (black), in presence of Ca2+ (orange), and in 
presence of Ca2+ and 540 µM cdG (red). Continuous lines represent the dRI signal (left axis), broken lines 
the MALS derived apparent mass values (right axis). (C) Compilation of MALS data (weight-average 
molecular mass) acquired at various loading concentrations for wild-type YahA-EAL. Data shown are for 
the apo protein (black), for the binary complexes with Mg2+ (light-green)  or Ca2+ (orange) and for the 
ternary complexes (molar cdG:protein ratio, 3:1) with cdG/Mg2+ (green) or cdG/Ca2+ (red). The data were 
fitted with a dynamic monomer - dimer model in fast exchange with the values of the pure species set to 
their nominal values (horizontal lines). The derived Kd values are listed in Tab. 4.
FIGURE 7. Analytical ultracentrifugation sedimentation equilibrium (AUC-SE) data for YahA-EAL in 
presence of 2 mM CaCl2. Protein and substrate concentrations are indicated. For each sample, data are 
shown for three speeds (9700, 16500, and 28000 rpm). All six runs were fitted globally to a dynamic 
monomer - dimer self-association model with the monomer mass set to 31 kDa. The fit yielded a 
dimerization Kd of 0.5 µM (Tab. 4).
FIGURE 8. Catalytic activity of the YahA-EAL domain. (A) FPLC chromatograms showing time 
dependent conversion of cdG to pGpG. CdG (200 µM) was incubated for the indicated time spans with 1 
µM YahA-EAL. (B) Progress curves of pGpG production with initial cdG substrate concentrations 
indicated. Data were fitted to a simple Michaelis-Menten kinetics model. (C) Specific activity kcat,meas = 
vmax/[YahA-EAL] as function of [YahA-EAL] concentration, measured at saturating substrate 
concentration. For the wild-type protein (green), data points are shown from two separate experiments. 
The data were fitted (continuous line) to a simple monomer - dimer equilibrium model and indicate that 
the enzyme is inactive as monomer. Dimer interface mutants S298W (blue) is virtually inactive.
FIGURE 9. Thermodynamic scheme for YahA-EAL catalyzed cdG hydrolysis. Five YahA-EAL states 
that are in fast thermodynamic equilibrium are shown: monomeric YahA-EAL in the uncomplexed (0) and 
cdG (ring symbol) complexed (1) state as well as dimeric YahA-EAL in the uncomplexed (00) and singly 
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(10) or doubly (11) occupied dimeric state. Magnesium ions in sites M1 and M2 are indicated. The second 
order ligand (Ks1, Ks10, Ks11) and dimer (K00, K11) association constants and turn-over numbers (kcat,10 and 
kcat,11) are indicated. Assuming no cooperativity, Ks10 = Ks11 and kcat,10 = kcat,11. Monomeric YahA-EAL is 
inactive, due to the postulated absence of a divalent cation in site M2. Dimeric YahA-EAL hydrolyses 
cdG to yield the linear pGpG dinucleotide (opened ring symbol). 
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Table 1. Crystallization, crystallographic data collection and structure refinement statistics.
Crystal(Structure
(Construct)
YahA4EAL4apo
(pET21b:YahA96)
YahA4EAL/Mg2+
pET28a:YahA101)
YahA4EAL/cdG(/Ca2+
pET28a:YahA101)
CrystallizaIon
Protein(solu,on(in SEC(buffer(=(50(mM(Tris,(pH(8.0(and(250(mM(NaCl.
Protein(concentra,on((mg/ml) 8.0((=260(µM) 8.0((=260(µM) 8.0H10.0((=260H320µM)
Ligand((coHcrystalliza,on) 2(mM(MgCl2 2(mM(CaCl2(+(1:5(molar(
ra,o(of(cdG
Reservoir(solu,on( 40%(PEG200(and(100(
mM(NaHAcetate(pH(4.6
10(%(PEG(8000,(20%(ethylene(
glycol,(10%(of(amino(acid(
mixture*,(
100(mM(MES/Imidazole(pH(6.5
12.5%(w/v(PEG(1000,(
12.5%(w/v(PEG(3350,(
12.5%(v/v(MPD,(10(%(of(
alcohol(mixture**,(100(
mM(MES/Imidazole(pH(6.5
Cryoprotectant None None None
Data(collecIon
Detector(type MAR325 Pilatus(2M Pilatus(2M
Space(group I222 P21 P21
Cell(axes([Å]
a(=(73.6,
b(=(87.8,
c(=(94.7((((((
a(=(64.9,
b(=(109.6,
c(=(((81.8
a(=(56.7,
b(=(70.3,
c(=(66.6,
Angles([°] β(=(99.40 β(=(98.70
Resolu,on([Å]( 47H1.70((1.79H1.70) 110H2.40((2.53H2.40) 21H1.70((1.79H1.70)(
Unique(reflec,ons 34026 43912 56878
Redundancy 6.1((6.1) 3.4((3.3) 3.4((3.6)
Rmerge([%] 5.5((44.3) 5.3((44.9) 9.3((37.3)
I/σ(I)( 15.7((3.4) 14.6((2.3) 5.4((2.5)
Completeness([%] 99.8((100.0) 99.6((99.8) 99.8((100.0)
Refinement
Rwork/Rfree([%] 16.5/18.5 18.8/22.2 22.1/25.4
rmsd
((((((((Bond(length([Å] 0.011 0.011 0.010
((((((((Bond(angles([°] 1.45 1.46 1.51
No.(of(atoms
((((((((Protein 2107 7943 4090
((((((((Ligand 50 20 124
((((((((Metals H 2 4
((((((((Water 213 208 412
Average(BHfactor([Å2]
((((((((Protein((main(chain)( 21.8( 24.3 13.2
((((((((Protein((side(chain) 27.0 27.2 14.6
((((((((Nucleo,des H H 9.9
((((((((Metals H 12.5 12.9
((((((((Water 40.7 42.9 12.0
Other(ligands 37.0 40.2 25.5
Ramachandran(sta,s,cs([%]
(((((((Favored(regions 99.1 99.5 99.8
(((((((Allowed(regions 0.9 0.5 0.2
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PDB(code 4KIE 4LYK 4LJ3
Values in parentheses refer to the highest resolution bin.
*  Amino acid mixture = 200 mM of each of Sodium-L-glutamate, M DL-alanine, Glycine and L-Lysine 
HCl, 0.2 M DL-Serine. **  Alcohol mixture =  200 mM of each of 1,6-hexanediol, 1-butanol, (RS)-1,2- 
propanediol, 2-propanol, 1,4-butanediol and 1,3-propanediol.
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Table 2. Metal ion coordination distances [Å] in YahA-EAL/cdG/Ca2+.
( M1 M2
Residue4Atom Chain(A Chain(B Residue4Atom Chain(A Chain(B
E141HOE2 2.44 2.34 D263HOD1 2.11 2.14
N200HOD1 2.49 2.44 E319HOE1 2.42(/(2.62 HH
E232HOE1 2.33 2.28 E319HOE2 2.44 2.34
D262HOD1 2.37 2.49 D285HOD1 HH 2.68
D262HOD2 2.54 2.56 cdGHO1P 2.33 2.41
cdGHO2P 2.27 2.38 W11/09HO 2.52 2.46
W10/07HO 2.35 2.44 W39/111HO 2.33 2.35
W160/(HH 2.53 HH
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Table 3. Ligand dissociation constants [nM].
fl-cdG cdG 
 - Ca2+ + Ca2+  - Ca2+ + Ca2+ 
YahA-EAL 489 (281…876) 33 (12…80) 22 (6…107) < 1
YahA_EAL(S298W) 525 (310…883) 48 (21…90) 126 (15…526) < 1
CdG and fl-cdG (fluorescein labeled cdG) dissociation constants in absence and presence of 2 mM CaCl2 
measured by MST. [fl-cdG] = 60 nM, [protein] = 2 μM and 90 nM for the cdG competition experiments 
in absence and presence of CaCl2, respectively. Values are rounded to 2 digits, P = 0.95 confidence 
intervals are given in brackets assuming a 5 % error in the individual measurements.
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Table 4. Dimer dissociation constants in absence and presence of cdG.
method  Kd,00 = K00-1 [µM] Kd,11 = K11-1 [µM]
- cdG - cdG - cdG + cdG + cdG
- *) + Mg2+ + Ca2+ + Mg2+ + Ca2+
MALS (Fig. 3C) 188 (80…1.6e3) 36 (21…65) 13 (0.8…25) 1.1 (0.6…2.3) **) 0.6 (0.3…1.1) **)
AUC (Fig. 6) - - - - 0.4 (0.2…0.9)
activity (Fig. 5C)  - - - 0.5 (0.47…0.54) -
Molar cdG:protein ratio was 3:1 and divalent cation concentration 2 mM, where applicable. *) without 
divalent cations;  **) sample not fully complexed upon elution; ligand occupancy ~ 0.7 as derived from 
combined UV/RI measurement.  P = 0.95 confidence intervals are given in brackets assuming a 5 % 
error in the individual measurements.
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Figure 7
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Figure 8
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